Skip to main content
SpringerLink
Log in

Overcoming misled design and interpretation of randomised trials

  • CORRESPONDENCE
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Niedermaier T, Weigl K, Hoffmeister M, Brenner H. Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling. Eur J Epidemiol. 2017;32(6):481–93.

    Article  PubMed  Google Scholar 

  2. Bretthauer M, Gondal G, Larsen K, Carlsen E, Eide TJ, Grotmol T, et al. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). Scand J Gastroenterol. 2002;37(5):568–73.

    Article  PubMed  CAS  Google Scholar 

  3. Hoff G, Grotmol T, Skovlund E, Bretthauer M. Norwegian Colorectal Cancer Prevention Study G. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. Br Med J. 2009;338:b1846.

    Article  Google Scholar 

  4. Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. Br Med J. 2014;348:g2467.

    Article  Google Scholar 

  5. Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial–SCORE. J Natl Cancer Inst. 2011;103(17):1310–22.

    Article  PubMed  Google Scholar 

  6. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366(25):2345–57.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Atkin W, Wooldrage K, Parkin DM, Kralj-Hans I, MacRae E, Shah U, et al. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK flexible sigmoidoscopy screening randomised controlled trial. Lancet. 2017;389(10076):1299–311.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, Garcia FA, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315(23):2564–75.

    Article  PubMed  CAS  Google Scholar 

  9. Knudsen AB, Zauber AG, Rutter CM, Naber SK, Doria-Rose VP, Pabiniak C, et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US preventive services task force. J Am Med Assoc. 2016;315(23):2595–609.

    Article  CAS  Google Scholar 

  10. Fraser CG, Allison JE, Young GP, Halloran SP, Seaman H. A standard for faecal immunochemical tests for haemoglobin evaluation reporting (FITTER). Ann Clin Biochem. 2014;51(Pt 2):301–302. Available on: http://www.worldendo.org/wp-content/uploads/2016/08/weo_expert_working_group_fit_discussion_doc_no5_pu.pdf.

  11. Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer systematic review and meta-analysis. Ann Intern Med. 2014;160(3):171–81.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Gies A, Bhardwaj M, Stock C, Schrotz-King P, Brenner H. Quantitative fecal immunochemical tests for colorectal cancer screening. Int J Cancer. 2018;143(2):234–44.

    Article  PubMed  CAS  Google Scholar 

  13. Brenner H, Stock C, Hoffmeister M. In the era of widespread endoscopy use, randomized trials may strongly underestimate the effects of colorectal cancer screening. J Clin Epidemiol. 2013;66(10):1144–50.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany

    Tobias Niedermaier, Korbinian Weigl & Hermann Brenner

  2. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany

    Korbinian Weigl & Hermann Brenner

  3. Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany

    Hermann Brenner

Authors
  1. Tobias Niedermaier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Korbinian Weigl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hermann Brenner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tobias Niedermaier.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Niedermaier, T., Weigl, K. & Brenner, H. Overcoming misled design and interpretation of randomised trials. Eur J Epidemiol 33, 775–776 (2018). https://doi.org/10.1007/s10654-018-0419-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-018-0419-3

Keywords

Search

Navigation